Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component

PHASE4CompletedINTERVENTIONAL
Enrollment

1,370

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
MalariaMalaria in Pregnancy
Interventions
DIETARY_SUPPLEMENT

Multiple micronutrients supplements (MMS)

Vitamin A 800 mcg; vitamin E 10 mg; vitamin D 5 mcg; vitamin B1 1.4 mg; vitamin B2 1.4 mg;niacin 18 mg; vitamin B6 1.9 mg; vitamin B12 2.6 mcg; folic acid 400 mcg; vitamin C 70 mg; iron 30 mg; zinc 15 mg; copper 2 mg; selenium 65 mcg; iodine 150 mcg

DIETARY_SUPPLEMENT

Iron and folic acid (IFA)

Iron 60 mg and folic acid 400 mcg

DRUG

Chloroquine (CQ)

Tablets 100 mg of chloroquine base

DRUG

Sulphadoxyne-pyrimethamine (SP)

Tablets

Trial Locations (1)

BP 390

Centre Muraz, Bobo-Dioulasso

All Listed Sponsors
collaborator

Departments of Parasitology and Public Health, ITM, Antwerp, Belgium

UNKNOWN

collaborator

Centre Muraz

OTHER

collaborator

Laboratoire National de Santé Publique, Ouagadougou, Burkina Faso

UNKNOWN

lead

Institute of Tropical Medicine, Belgium

OTHER

NCT00680732 - Prevention of Intrauterine Growth Retardation in Burkina Faso: the Malaria Component | Biotech Hunter | Biotech Hunter